Trueblood Wealth Management’s Broadcom AVGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.47M Buy
6,539
+836
+15% +$335K 0.86% 20
2026
Q1
$1.77M Sell
5,703
-54
-0.9% -$17.8K 0.69% 38
2025
Q4
$1.99M Sell
5,757
-356
-6% -$127K 0.78% 29
2025
Q3
$2.02M Buy
6,113
+3
+0% +$920 0.79% 26
2025
Q2
$1.68M Buy
6,110
+53
+0.9% +$11.5K 0.7% 34
2025
Q1
$1.01M Buy
6,057
+239
+4% +$50.6K 0.47% 73
2024
Q4
$1.35M Buy
5,818
+256
+5% +$47.3K 0.66% 38
2024
Q3
$959K Buy
5,562
+212
+4% +$34K 0.48% 68
2024
Q2
$859K Buy
5,350
+50
+0.9% +$7.01K 0.48% 69
2024
Q1
$702K Sell
5,300
-460
-8% -$57K 0.4% 81
2023
Q4
$643K Buy
+5,760
New +$545K 0.4% 81

Other funds holding AVGO

Trueblood Wealth Management's AVGO Position: Q2 2026 in Review

Trueblood Wealth Management increased its Broadcom (AVGO) stake by 15% in Q2 2026, buying an estimated $335K and bringing the position to 6,539 shares worth $2.47M. The position accounts for 0.86% of the portfolio, ranked #20.

Trueblood Wealth Management first reported a position in AVGO in Q4 2023 and has held it in 11 quarters since. 4,819 funds tracked by Wall St. Rank hold AVGO as of Q2 2026.

  • Trueblood Wealth Management held 6,539 shares of Broadcom worth $2.47M as of Q2 2026.
  • Trueblood Wealth Management bought 836 Broadcom shares in Q2 2026, an estimated $335K.
  • Broadcom made up 0.86% of Trueblood Wealth Management's portfolio in Q2 2026, its #20 holding.
  • Trueblood Wealth Management first reported a position in Broadcom in Q4 2023 and has held it in 11 quarters since.
  • 4,819 funds tracked by Wall St. Rank held Broadcom as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.